Limitations, agreements, and source contact

Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis · Source last updated 2017-04-21

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restrictive Agreement

false

point Of Contact

email

DAITClinicalTrialsGov@niaid.nih.gov

organization

DAIT/NIAID

phone

(301) 594-7669

title

Associate Director, Clinical Research Program

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice